Aranesp (darbepoetin alfa)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aranesp (darbepoetin alfa), covering 2017-02-10 to 2017-02-10. Get the full timeline:
Most recent: Clinical Trial Update: Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy [Phase 2]